Cancer-Drug Costs Rise, Leaving Even Insured Patients with Financial Burden

As cancer rates rise for people under 50, the cost of life-saving treatment is rising far past their ability to pay.
Cancer-Drug Costs Rise, Leaving Even Insured Patients with Financial Burden
Artem Oleshko/Shutterstock
|Updated:
0:00

An increase in cancer cases is putting pressure on Americans.

With medical debt burdening patients, the battle against cancer is taking a new financial front that could affect many cancer patients’ lives.

Emerging Patterns in Cancer Data

For more than seven decades, cancer has remained among the top two leading causes of death. Well over one-third of the U.S. population will confront a cancer diagnosis during their lifetime, according to National Cancer Institute estimates.
George Citroner
George Citroner
Author
George Citroner reports on health and medicine, covering topics that include cancer, infectious diseases, and neurodegenerative conditions. He was awarded the Media Orthopaedic Reporting Excellence (MORE) award in 2020 for a story on osteoporosis risk in men.
Related Topics